| 1 |
34751390 | Capsaicin restores sodium iodine symporter-mediated radioiodine uptake through bypassing canonical TSH‒TSHR pathway in anaplastic thyroid carcinoma cells. | 2022 Jan 21 |
2 |
| 2 |
33947272 | Changes in Thyrotropin Receptor Antibody Levels Following Total Thyroidectomy or Radioiodine Therapy in Patients with Refractory Graves' Disease. | 2021 Aug |
1 |
| 3 |
34747364 | Unilateral gynecomastia as an initial presentation of hyperthyroid Graves' disease. | 2021 Nov 1 |
1 |
| 4 |
32300552 | Nevirapine Increases Sodium/Iodide Symporter-Mediated Radioiodide Uptake by Activation of TSHR/cAMP/CREB/PAX8 Signaling Pathway in Dedifferentiated Thyroid Cancer. | 2020 |
1 |
| 5 |
30426886 | Incidence of Neonatal Hyperthyroidism Among Newborns of Graves' Disease Patients Treated with Radioiodine Therapy. | 2019 Jan |
2 |
| 6 |
30944161 | Nanoparticles Bearing TSH Receptor Protein and a Tolerogenic Molecule Do Not Induce Immune Tolerance but Exacerbate Thyroid Autoimmunity in hTSHR/NOD.H2h4 Mice. | 2019 May 1 |
2 |
| 7 |
29845889 | Structure of a Thyrotropin Receptor Monoclonal Antibody Variable Region Provides Insight into Potential Mechanisms for its Inverse Agonist Activity. | 2018 Jul |
2 |
| 8 |
29137069 | Graves disease following radioiodine therapy for toxic adenoma: Clinical case report. | 2017 Nov |
1 |
| 9 |
27534827 | Efficacy and safety of radioiodine therapy for mild Graves ophthalmopathy depending on cigarette consumption: a 6‑month follow‑up. | 2016 Aug 18 |
1 |
| 10 |
24353283 | Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics. | 2014 Apr |
2 |
| 11 |
22898315 | Re-induction of cell differentiation and (131)I uptake in dedifferentiated FTC-133 cell line by TSHR gene transfection. | 2012 Nov |
2 |
| 12 |
24782994 | Pre-conception counselling in graves' disease. | 2012 Apr |
1 |
| 13 |
18166819 | TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. | 2008 Jan |
3 |
| 14 |
19169486 | Seven-year follow-up of a juvenile female with papillary thyroid carcinoma with poor outcome, BRAF mutation and loss of expression of iodine-metabolizing genes. | 2008 Nov |
2 |
| 15 |
19175067 | Why does the patient with Graves' disease remain euthyroid/mildly hyperthyroid following total thyroidectomy--the role of thyrotropin receptor antibodies (TRAb) and vestigial remnants of the thyroglossal tract. | 2008 Sep |
1 |
| 16 |
17198353 | Induction of stimulating thyrotropin receptor antibodies after radioiodine therapy for toxic multinodular goitre and Graves' disease measured with a novel bioassay. | 2007 Feb |
1 |
| 17 |
16571091 | Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease. | 2006 Mar |
3 |
| 18 |
17154095 | [Current problems in the treatment of Graves' disease in pregnancy and in lactation]. | 2006 Dec |
1 |
| 19 |
16021986 | Use of anti-thyroid drugs in euthyroid pregnant women with previous Graves' disease. | 2005 Jun |
1 |
| 20 |
15127319 | TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre. | 2004 Apr |
2 |
| 21 |
15255314 | [Radioiodine therapy for Graves' disease: problems and new developments]. | 2004 May |
1 |
| 22 |
12695788 | [Predictive value of thyrotropin receptor antibodies using the second generation TRAb human assay after radioiodine treatment in Graves' disease]. | 2003 |
1 |
| 23 |
12727856 | Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing. | 2003 May 1 |
1 |
| 24 |
11833000 | Induction of TSH-receptor antibodies in patients with toxic multinodular goitre by radioiodine treatment. | 2002 Jan |
3 |
| 25 |
12487767 | Epidemiology and prevention of Graves' ophthalmopathy. | 2002 Oct |
1 |
| 26 |
9987776 | [Cost-effectiveness analysis: radioiodine or antithyroid medication in primary treatment of immune hyperthyroidism]. | 1999 |
1 |
| 27 |
10195384 | Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma. | 1999 Feb |
2 |
| 28 |
10355051 | Antithyroid drug therapy: predictive parameters. | 1999 Apr |
1 |
| 29 |
10365679 | Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy. | 1999 May |
1 |
| 30 |
10544750 | [Pregnancy and the thyroid gland]. | 1999 Sep |
1 |
| 31 |
9284721 | Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter. | 1997 Sep |
2 |
| 32 |
9007700 | Relationship between thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins years after administration of radioiodine for Graves' disease: retrospective clinical survey. | 1996 Nov |
1 |
| 33 |
7621571 | Long-term effects of radioiodine on thyrotrophin receptor antibodies in Graves' disease. | 1995 May |
1 |
| 34 |
8033373 | Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre. | 1994 Jun |
3 |
| 35 |
1349025 | Hyperthyroid Graves' disease without detectable thyrotropin receptor antibodies. | 1992 May |
1 |
| 36 |
1687028 | Thyrotropin receptor antibody activities significantly correlate with the outcome of radioiodine (131I) therapy for hyperthyroid Graves' disease. | 1991 Aug |
3 |
| 37 |
1980206 | Changes in the properties of the thyrotropin receptor antibody in patients with Graves' disease after radioiodine treatment. | 1990 Jan |
2 |
| 38 |
2484872 | Changes in the properties of the thyrotropin receptor antibody in patients with Graves' disease after radioiodine treatment. | 1989 Dec |
2 |
| 39 |
2869050 | Methimazole, but not betamethasone, prevents 131I treatment-induced rises in thyrotropin receptor autoantibodies in hyperthyroid Graves' disease. | 1986 Apr |
1 |